Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study

Tekijä Reza Ramazani Khorshiddoust, Saleh Ramazani Khorshiddoust, Tahereh Hosseinabadi, Faezeh Mottaghitalab, Farzad Mokhtari, Fatemeh Azadinia, Hossein Mozdarani, Mohammad Shabani, Hamid Emadi-Kouchak, Bahram Taheri, Fatemeh Khani-Juyabad, Mina Amjadi Kashani, Arezoo Sadoughi, Sorour Zamanizadeh, Hadyeh Maddah, Maedeh Aminzadeh, Maryam Khanaki, Sabereh Saremi, Anahita Pashaee Rad, Ali Fatehi, Melika Ghaznavi Rad, Masoud Haftbaradaran, Mehran Khosroshahi, Mahtab Sadeghi, Majid Aminnayeri, Sirous Jafari, Fereshteh Ghiasvand, Arash Seifi, Sara Ghaderkhani, Seyed Ali Dehghan Manshadi, Mohammadreza Salehi, Ladan Abbasian, Malihe Hasannezhad, Mohsen Meidani, Mahboubeh Hajiabdolbaghi, Zahra Ahmadinejad, Masoud Parash, Zahra Sedighi, Abdorreza Mohammadian
Julkaistu 2022-05-01